하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.
하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
Hironic Co., Ltd., a company specializing in aesthetic medical devices, announced on the 18th that it will showcase its new product, “MIGLOU,” at “KIMES 2026” (Korea International Medical & Hospital Equipment Show), the largest medical device exhibition in Korea.
KIMES is Korea’s premier medical device exhibition, offering a comprehensive look at the latest trends and technologies in the medical industry. It is a major global medical industry event that attracts a massive number of domestic and international medical device companies, medical professionals, and buyers each year. At KIMES 2026, a variety of cutting-edge medical devices and smart healthcare technologies are scheduled to be introduced.
During this exhibition, Hironic plans to capture the attention of domestic and international medical professionals and buyers by showcasing its new product 'MIGLOU' alongside its core lineup of aesthetic medical devices.
MIGLOU is a device designed based on 2.45GHz Ultra-High Frequency (UHF) technology. By applying CNF (Complex Near Focusing) matching technology, it enables highly precise energy delivery to the target area.
Additionally, it features a safety-focused design that utilizes a contact cooling system and built-in handpiece sensors during treatments. Its utility is further enhanced by supporting a variety of handpieces designed for both face and body care.
Throughout the KIMES 2026 exhibition, Hironic plans to directly demonstrate MIGLOU's technological capabilities to medical professionals and buyers through on-site demonstrations and product consultations. Furthermore, as part of its strategy to expand into the global market, Hironic will actively seek collaborative opportunities with international medical professionals and partners, and conduct business meetings with overseas buyers.
An official from Hironic stated, "MIGLOU, which we are unveiling at KIMES 2026, is a device developed to reflect the diverse needs of the aesthetic dermatology market." The official added, "Through continuous research and development, we plan to keep introducing innovative solutions that enhance satisfaction for both medical professionals and patients."
Meanwhile, Hironic has been bolstering its competitiveness in the aesthetic medical device market through ongoing investments in Research and Development (R&D) and the expansion of its global distribution network. The company recently solidified its foundation for growth by securing a strategic investment from Cactus Private Equity (Cactus PE). Building on this momentum, Hironic is expected to continuously drive the development of next-generation technologies in the medical aesthetic field and further expand its presence in the global market.
